Vertebral bone mineral density changes in female rheumatoid arthritis patients treated with low-dose methotrexate

Clinical and Experimental Rheumatology

Volumn 18, Issue 3, 2000, Pages 327-331

  Mazzantini, M ^a   Di Munno, O ^a   Incerti Vecchi, L ^a   Pasero, G ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Methotrexate; Osteoporosis; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; METHOTREXATE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DOSE RESPONSE; FEMALE; HUMAN; LUMBAR SPINE; OSTEOPOROSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TRABECULAR BONE; VERTEBRA;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BONE DENSITY; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUMBAR VERTEBRAE; METHOTREXATE; MIDDLE AGED; OSTEOPOROSIS; PROSPECTIVE STUDIES;

EID: 0034047128     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. LAAN RFJM, VAN RIEL PLCM, VAN DEN PUTTE LBA: Bone mass in patients with rheumatoid arthritis. Ann Rheum Dis 1992; 51: 826-32.
2. FOGLEMAN I: Rheumatoid arthritis and osteoporosis. Br J Rheumatol 1986; 25: 240-2.
3. GOUGH AKS, LILEY J, EYRE S, HOLDER RL, EMERY P: Generalized bone loss in patients with early rheumatoid arthritis. Lancet 1994; 344: 23-7.
4. LAAN RFJM, VAN RIEL PLCM, VAN EARNING LJTH, LEMMENS JAM, RUIJS SHJ, VAN DEN PUTTE LBA: Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisolone therapy. Br J Rheumalol 1992; 31: 91-6.
5. LAAN RFJM, VAN DEN PUTTE LBA, VAN RIEL PLCM, VAN EARNING LJTH, VAN'T HOF MA, LEMMENS AM: Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. Ann Intern Med 1993; 119: 963-8.
6. EASTGATE JA, WOOD NC, DI GIOVINE FS, SYMONS JA, GRINLINTON FM, DUFF GW: Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis. Lancet 1988; 340: 706-9.
7. PRESTON SJ, DIAMOND T, SCOTT A, LAURENT MR: Methotrexate osteopathy in rheumatic disease. Ann Rheum Dis 1993;52:582-5.
8. SHAPIRA D, SCHARF Y: Insufficiency fracture of the distal tibia mimicking arthritis in a rheumatoid arthritis patient. The possible role of methotrexate treatment. Clin Exp Rheumatol 1995; 13: 130-1.
9. BOLOGNA C, SANY J, JORGENSEN C: Possible role of methotrexate in the distal tibiae fractures in a patient with rheumatoid arthritis. Clin Exp Rheumatol 1996; 14: 343-52.
10. MAENAUT K, WESTHOVENS R, DEQUEKER J: Methotrexate osteopathy. Does it exist? J Rheumalol 1996; 23: 2156-9.
11. RAGAB AH, FRECH RS, VIETTI TJ: Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission. Cancer 1970; 25: 580-5.
12. NESBIT M, KRIVIT W, HEYN R, SHARP H: Acute and chronic effects of methotrexate on hepatic, pulmonary and skeletal systems. Cancer 1976; 37: 1048-54.
13. STANISAVLJEVIC S, BABCOCK AL: Fractures in children treated with methotrexate for leukemia. Clin Orthop 1977; 125: 139-44.
14. SCHWARTZ AM, LEONIDAS JC: Methotrexate osteopathy. Skel Radiol 1984; 11: 13-6.
15. BOLOGNA C, EDUO L, ANAYA JM, et al.: Methotrexate concentrations in synovial membrane and trabecular and cortical bone in rheumatoid arthritis patients. Arthritis Rheum 1994; 37: 1770-3.
16. MAY K, WEST SG, MCDERMOTT MT, HUFFER WE: The effect of low-dose methotrexate on bone metabolism and histomorphometry in nix. Arthritis Rheum 1944; 37: 201-6.
17. MAY K, MERCIEL D, MCDERMOTT MT, WEST SG: The effect of methotrexate on mouse bone cells in culture. Arthritis Rheum 1996; 39: 484-94.
18. VAN DEN VEEN MJ, SCHEVEN BAA, VAN ROY JLAM, DAMEN CA, LAFEBER FPJG, BULSMA JWJ: In vitro effects of methotrexate on human articular cartilage and bone-derived osteoblasts. Br J Rheumatol 1996; 35: 342-9.
19. KATZ JN, LEBOFF MS, WADE JP, BROWN EM, LIANG, MH: Effect of methotrexate and calcium homeostasis in rheumatoid arthritis. Clin Res 1989; 37: 509A.
20. CARBONE LD, KAELEY G, MCKOWN KM, CREMER M, PALMIERI G, KAPLAN S: Effects of long term administration of methotrexate on bone mineral density in rheumatoid arthritis. Calcif Tissue Int 1999; 64: 100-1.
21. BUCKLEY LM, LEIB ES, CARTULARO KS, VACEK PM, COOPER SM: Effects of low dose MTX on the bone mineral density of patients with RA. J Rheumatol 1997; 24: 1489-44.
22. ARNETT FR, EDWORTHY SM, BLOCH DA, et al.: The 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
23. STEINBROCKER O, TRAEGER CH, BATTERMAN EC: Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659-62.
24. RITCHIE DM, BOYLE JA, MCINNES JM et al.: Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968; 37: 393-406.
25. WEINBLATT ME, KAPLAN H, GERMAIN BF et al.: Methotrexate in rheumatoid arthritis: a five-year prospective multicenter study. Arthritis Rheum 1994: 37: 1492-8.
26. SEGAL R, MOZES E, YARON M, TARTAKOVSKY B: The effects of methotrexate on the production and activity of interleukin 1. Arthritis Rheum 1989; 32: 370-7.
27. RANJENY T, GRAEME JC: Reduction of leucocyte and interleukin-1β concentrations in the synovial fluid of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 1993; 36: 1244-52.
28. SHORE A, JAGLAL S, KEYSTONE EC: Enhanced interleukin-1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis. Clin Exp Immunol 1986; 65: 293-302.
29. SEGAWA Y, YAMAURA M, AOTA S, et al.: Methotrexate maintains bone mass by preventing both a decrease in bone formation and an increase in bone resorption in adjuvant-induced arthritic rats. Bone 1997; 20: 457-64.
30. SCHNEIDER R, KAYE JJ: Insufficiency and stress fracture of the long bones occurring in patients with rheumatoid arthritis. Radiology 1475; 116: 595-9.
31. YOUNG A, KINSELLA P, BOLAND P: Stress fractures of the lower limb in patients with rheumatoid arthritis. J Rone Joint Surg 1983; 63B; 239-43.
32. PRESTON SJ, CLIFTON-BLIGH P, LAURENT MR, JACKSON C, MASON RS: Effect of methotrexate and sulphasalazine on UMR 106 rat osteosarcoma cells. Br J Rheumatol 1997; 36: 178-84.